Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. earway

EarWay

EarWay: a simple, safe and efficient medical device for earwax removal

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EarWay project word cloud

Explore the words cloud of the EarWay project. It provides you a very rough idea of what is the project "EarWay" about.

usa    900    validated    founded    depression    return    innovator    ent    people    innovative    treatments    patient    care    hearing    ultimately    impacted    1bn    odour    clinically    healthcare    billion    suction    physicians    solutions    suffer    discomfort    15    treatable    treatment    ringing    practitioners    safe    children    tinnitus    earwax    severe    itching    disorders    isolation    slow    designed    cognition    twist    patients    removal    specialists    burden    million    recurrent    minutes    earway    tools    background    reg    200    waiting    irrigation    symptoms    power    medical    122    release    ltd    alone    earways    allowed    1st    cerumen    pro    ear    scarce    uncountable    primary    empowerment    successful    homecare    represented    87    fast    throat    consequently    clinicians    professional    market    shift    ranging    times    paranoia    extraction    approximately    90    millions    acute    impaired    provides    time    discharge    speech    impaction    pain    reducing    nose    micro    home    diseases    professionals    social    adults    carers    worldwide   

Project "EarWay" data sheet

The following table provides information about the project.

Coordinator		 EARWAYS MEDICAL LTD 

Organization address
address: HAMELACHA 23 ST.
city: ROSH HAAYIN
postcode: 4809173
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Israel [IL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EARWAYS MEDICAL LTD IL (ROSH HAAYIN) coordinator 50˙000.00

Map

 Project objective

Approximately 1.1bn (15%) of the people worldwide suffer from recurrent cerumen impaction, being the 1st reason worldwide of treatable hearing loss. Impacted earwax can cause uncountable symptoms ranging from ear pain, itching, ringing (tinnitus) and discharge/odour to more severe diseases like hearing loss and eventually depression, paranoia, impaired cognition and speech disorders, and consequently social isolation. Current professional tools are complex and slow: many of these methods (e.g., irrigation) cause patient discomfort and are associated to treatments that are long (15-40 minutes) and often complex (e.g, micro suction) therefore not viable for General Practitioners and only allowed for the scarce Ear Nose and Throat specialists (ENT´s) associated with long waiting times for patients. To solve this, healthcare organizations are promoting the empowerment of patients via the shift to homecare solutions. Based on an innovative “release with a twist” principle, the products EarWay®Pro and EarWay®HomeCare are designed to enable simple cerumen extraction and management of earwax impaction. Their background technology provides safe, effective (87% success) and fast (90% reduced treatment time) devices that have been clinically validated in 200 successful earwax removal cases by both primary carers ) and specialists. Moreover they return the power to the primary-care professionals (EarWay®Pro) and the patient (EarWay®HomeCare) ultimately reducing the burden for the healthcare system. EarWay® products are targeting a large market of €7.3 billion in Europe and USA alone, including a €5.8 billion HomeCare market represented by over 122 million cerumen-impacted people and the €1.5-billion Pro market with over 900,000 target physicians. EARWAYS MEDICAL LTD. is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, providing easy-to-use ear-care products for both clinicians and home use.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EARWAY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EARWAY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More